Orthopedic medical device manufacturer Zimmer may be facing more lawsuits after a recent Zimmer Persona Knee recall.
The company issued a worldwide voluntary recall of its Persona Trabecular Metal Tibial Plate, a component used in the Zimmer Persona Knee, on March 3, 2015. The U.S. Food and Drug Administration (FDA) announced an official recall less than two weeks later.
The recall was issued after Zimmer received multiple reports about premature loosening and radiolucent lines on x-rays that indicate a gap between the metal plate and the bone.
Zimmer touted the Persona knee as the “… most clinically successful knee replacement more personalized than ever.” Similar statements were made regarding the Zimmer’s NexGen Knee – which is also the subject of lawsuits because of a high early failure rate.
“NexGen is clinically proven and the most trusted knee replacement system in the world,” according to Zimmer’s website. Like NexGen patients, Persona knee recipients may be required to undergo additional corrective surgeries. Many NexGen recipients who required a revision surgery have filed Zimmer lawsuits seeking compensation.
Anapol Schwartz Zimmer knee recall lawyers Jim Ronca and Melissa Hague represent numerous clients who experienced serious NexGen complications and will be representing a Philadelphia woman in one of the first Zimmer Knee lawsuits to go to trial. In addition to their advocacy for injured NexGen patients, Anapol Schwartz recently began investigating Zimmer Persona knee lawsuits.
The Zimmer Persona recall affects more than 12,000 metal plates worldwide. In the U.S, the recalled device was distributed to hospitals in at least 25 states and 13 Veterans Administration hospitals between November 29, 2012 and January 23, 2015.
Joshua C. Cohan joined Anapol Weiss as an associate in 2013 and is a member of the firm’s Mass Tort Team. His practice focuses on pharmaceutical and medical device mass tort litigation involving complex medical, scientific, and legal issues.